Fosamax Plus D Merck & Co., Inc. - Treatment for Osteoporosis
Fosamax Plus D is a single once-weekly tablet containing the
bisphosphonate drug alendronate, and seven days’ worth of
vitamin D, an essential nutrient required for calcium absorption.
Fosamax Plus D is used to reduce the risk of hip and spinal
fractures in postmenopausal women with osteoporosis, and to
increase bone mass in men with osteoporosis.
Posted: April 2005
Fosamax Plus D (alendronate and cholecalciferol) FDA Approval History